Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Otto C. Boerman"'
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-9 (2019)
Ejnmmi Research, 9, 108
Ejnmmi Research, 9, 1, pp. 108
EJNMMI Research
Ejnmmi Research, 9, 108
Ejnmmi Research, 9, 1, pp. 108
EJNMMI Research
Background In colorectal cancer, survival of patients is drastically reduced when complete resection is hampered by involvement of critical structures. Targeted photodynamic therapy (tPDT) is a local and targeted therapy which could play a role in er
Autor:
Johan F. Langenhuijsen, Tim J. van Oostenbrugge, Peter F.A. Mulders, Jurgen J. Fütterer, Otto C. Boerman, Sjoerd F. M. Jenniskens, Egbert Oosterwijk, Wim J.G. Oyen
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 47, 1864-1870
European Journal of Nuclear Medicine and Molecular Imaging, 47, 8, pp. 1864-1870
European Journal of Nuclear Medicine and Molecular Imaging, 47, 8, pp. 1864-1870
Purpose Detection of residual or recurrent vital renal tumor on follow-up (FU) cross-sectional imaging after ablative therapy is challenging. The specific and high expression levels of carbonic anhydrase IX (CAIX) in clear cell renal cell carcinoma (
Autor:
Ralf Hosse, Federica Cavallo, Esther Bommer, Danny Gerrits, Valeria Gonzalez-Nicolini, Marina Bacac, Volker Teichgräber, Stefan Evers, Gregory O. Dugan, Tapan K. Nayak, Erwin van Puijenbroek, Inja Waldhauer, Elisabeth Husar, J. Mark Cline, Virginie Steinhart, Gonzalo Acuna, Ekkehard Moessner, Markus Neubauer, Johannes Sam, Edwin J. W. Geven, Pradeep Garg, Sabine Lang, Jehad Charo, Sara Colombetti, Christian Klein, Linda Fahrni, Anne Freimoser-Grundschober, Otto C. Boerman, Pablo Umana
Publikováno v:
mAbs
article-version (VoR) Version of Record
Mabs, 13
Mabs, 13, 1
article-version (VoR) Version of Record
Mabs, 13
Mabs, 13, 1
Simlukafusp alfa (FAP-IL2v, RO6874281/RG7461) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAP) and an IL-2 variant with a retained affinity for IL-2Rβγ > IL-2 Rβγ and abolished binding to IL-2 Rα. Here,
Autor:
Wim J.G. Oyen, Otto C. Boerman, T.J. Van Oostenbrugge, Sjoerd F. M. Jenniskens, Egbert Oosterwijk, P.F.A. Mulders, J.J. Fütterer, Johan F. Langenhuijsen
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e1966-e1967 (2020)
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity
Autor:
Otto C. Boerman, Sandra Heskamp, Uwe Karst, Nicola Margiotta, Michele Iafisco, Michael Brand, Martin Bornhaeuser, Karlijn Codee-van der Schilden, Nandini Asokan, Barbara Crone, Robin A. Nadar, Sander C.G. Leeuwenburgh, Kambiz Farbod, Alessandra Curci, Jeroen J.J.P. van den Beucken, Lukas Schlatt
Publikováno v:
Scientific Reports
Scientific Reports, 10
Scientific reports (Nature Publishing Group) 10 (2020). doi:10.1038/s41598-020-62039-2
info:cnr-pdr/source/autori:Nadar, Robin A.; Farbod, Kambiz; Codee-van der Schilden, Karlijn; Schlatt, Lukas; Crone, Barbara; Asokan, Nandini; Curci, Alessandra; Brand, Michael; Bornhaeuser, Martin; Iafisco, Michele; Margiotta, Nicola; Karst, Uwe; Heskamp, Sandra; Boerman, Otto C.; van den Beucken, Jeroen J. J. P.; Leeuwenburgh, Sander C. G./titolo:Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity/doi:10.1038%2Fs41598-020-62039-2/rivista:Scientific reports (Nature Publishing Group)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:10
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Scientific Reports, 10
Scientific reports (Nature Publishing Group) 10 (2020). doi:10.1038/s41598-020-62039-2
info:cnr-pdr/source/autori:Nadar, Robin A.; Farbod, Kambiz; Codee-van der Schilden, Karlijn; Schlatt, Lukas; Crone, Barbara; Asokan, Nandini; Curci, Alessandra; Brand, Michael; Bornhaeuser, Martin; Iafisco, Michele; Margiotta, Nicola; Karst, Uwe; Heskamp, Sandra; Boerman, Otto C.; van den Beucken, Jeroen J. J. P.; Leeuwenburgh, Sander C. G./titolo:Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity/doi:10.1038%2Fs41598-020-62039-2/rivista:Scientific reports (Nature Publishing Group)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:10
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Platinum-based chemotherapeutics exhibit excellent antitumor properties. However, these drugs cause severe side effects including toxicity, drug resistance, and lack of tumor selectivity. Tumor-targeted drug delivery has demonstrated great potential
Autor:
Janneke D.M. Molkenboer-Kuenen, Ha-Long Nguyen, Miikka Vikkula, Daphne Lobeek, Mark Rijpkema, Laurence M. Boon, Erik H.J.G. Aarntzen, Willemijn M. Klein, Frédérique C.M. Bouwman, Leo J. Schultze Kool, Wim J.G. Oyen, Uta Flucke, Otto C. Boerman, Peter Laverman, Samantha Y.A. Terry
Publikováno v:
The Journal of Nuclear Medicine (1978), 61, 2, pp. 270-275
The Journal of Nuclear Medicine (1978), 61, 270-275
The Journal of Nuclear Medicine (1978), 61, 270-275
Arteriovenous malformations (AVMs) have an inherent capacity to form new blood vessels, resulting in excessive lesion growth, and this process is further triggered by the release of angiogenic factors. 68Ga-labeled arginine-glycine-aspartate tripepti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b2444d518f4ce7cf2fa0ff494833624
https://hdl.handle.net/2066/216641
https://hdl.handle.net/2066/216641
Autor:
Otto C. Boerman, Imke Schuurmans, James Nagarajah, Thomas Crezee, Johannes W. A. Smit, Marika H Tesselaar, Danny Gerrits, Theo S. Plantinga, Ilse van Engen-van Grunsven, Romana T. Netea-Maier
Publikováno v:
The Journal of Nuclear Medicine (1978), 59, 780-786
The Journal of Nuclear Medicine (1978), 59, 5, pp. 780-786
The Journal of Nuclear Medicine (1978), 59, 5, pp. 780-786
Anaplastic thyroid cancer (ATC) is a rare malignancy that accounts for 1%-2% of all thyroid cancers. ATC is one of the most aggressive human cancers, with rapid growth, tumor invasion, and development of distant metastases. The median survival is onl
Autor:
Erik J van Helden, Sjoerd G. Elias, Henk M.W. Verheul, Elisabeth G.E. de Vries, Suzanne C van Es, Astrid Aplonia Maria Van Der Veldt, Sarah R. Verhoeff, Erik H.J.G. Aarntzen, Sjoukje F. Oosting, Winette T. A. van der Graaf, Sandra Heskamp, Otto S. Hoekstra, Otto C. Boerman, Lindsay Angus, Wim J.G. Oyen, Carla M.L. van Herpen, Thomas C. Kwee, Adrienne H. Brouwers, Eline Boon
Publikováno v:
Verhoeff, S R, van Es, S C, Boon, E, van Helden, E, Angus, L, Elias, S G, Oosting, S F, Aarntzen, E H, Brouwers, A H, Kwee, T C, Heskamp, S, Hoekstra, O S, Verheul, H, van der Veldt, A A M, de Vries, E G E, Boerman, O C, van der Graaf, W T A, Oyen, W J G & van Herpen, C M L 2019, ' Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 9, pp. 1931-1939 . https://doi.org/10.1007/s00259-019-04358-9
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46, 1931-1939
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 46, 9, pp. 1931-1939
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46, 1931-1939
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 46, 9, pp. 1931-1939
Purpose The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate the lesion detection of baseline contrast-enhanced CT, [89Zr]Zr-DFO-girentuximab-PET/CT an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18fa35968023bca2a3e9f115930859d3
https://dspace.library.uu.nl/handle/1874/389954
https://dspace.library.uu.nl/handle/1874/389954
Autor:
Gerben Franssen, Dennis W. P. M. Löwik, Sandra Heskamp, S. Lütje, Otto C. Boerman, A. Kip, Helene I. V. Amatdjais-Groenen, Y. Derks
Publikováno v:
57. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
Otto C. Boerman, Dennis W. P. M. Löwik, Martin Gotthardt, Susanne Lütje, Sandra Heskamp, J.P. Michiel Sedelaar, Yvonne H.W. Derks, Mark Rijpkema
Publikováno v:
Theranostics, 9, 6824-6839
Theranostics
Theranostics, 9, 23, pp. 6824-6839
Theranostics
Theranostics, 9, 23, pp. 6824-6839
Contains fulltext : 215222.pdf (Publisher’s version ) (Open Access) Despite recent improvements in imaging and therapy, prostate cancer (PCa) still causes substantial morbidity and mortality. In surgical treatment, incomplete resection of PCa and u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45afd1748670a6d679dbeacf0626270d
http://hdl.handle.net/2066/215222
http://hdl.handle.net/2066/215222